Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Boston Scientific's
Operating Income
for the
three
months ended in Jun. 2022 was $518 Mil. Boston Scientific's Interest Expense for the
three
months ended in Jun. 2022 was $-64 Mil.
Boston Scientific's interest coverage for the quarter that ended in Jun. 2022 was 8.09.
The higher the ratio, the stronger the company's financial strength is.
The historical rank and industry rank for Boston Scientific's Interest Coverage or its related term are showing as below:
BSX'
s Interest Coverage Range Over the Past 10 Years
Min: 1.89 Med: 3.93 Max: 6.88
Current: 3.75
BSX's Interest Coverage is ranked worse than 90.65% of 428
companies
in the Medical Devices & Instruments industry
Industry Median: 38.10
vs BSX: 3.75
Boston Scientific Interest Coverage Historical Data
The historical data trend for Boston Scientific's Interest Coverage can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Boston Scientific Annual Data
Trend
Dec12
Dec13
Dec14
Dec15
Dec16
Dec17
Dec18
Dec19
Dec20
Dec21
Interest Coverage
6.69
6.88
3.68
1.89
5.35
Boston Scientific Quarterly Data
Sep17
Dec17
Mar18
Jun18
Sep18
Dec18
Mar19
Jun19
Sep19
Dec19
Mar20
Jun20
Sep20
Dec20
Mar21
Jun21
Sep21
Dec21
Mar22
Jun22
Interest Coverage
6.06
5.33
5.51
1.73
8.09
Competitive Comparison
For the Medical Devices subindustry, Boston Scientific's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Boston Scientific Interest Coverage Distribution
For the Medical Devices & Instruments industry and Healthcare sector, Boston Scientific's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Boston Scientific's Interest Coverage falls into.
Boston Scientific Interest Coverage Calculation
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Boston Scientific (NYSE:BSX) Interest Coverage Explanation
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Boston Scientific Interest Coverage Related Terms
Thank you for viewing the detailed overview of Boston Scientific's Interest Coverage provided by GuruFocus.com. Please click on the following links to see related term pages.
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, cardiac rhythm management, catheter-directed ultrasound imaging, structural heart disease, upper gastrointestinal tract diagnostics, interventional oncology, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.
My Portfolios
Create New Portfolio
Portfolio Contest
My Gurus
Personalize
Premium Gurus 
0.61(1.43%) Volume: 5,396,831 4:00PM EDT
Email Alerts
Stock PDF
RSS
Website
Filings
Download
Manual of Stocks™ Web APP
NYSE:BSX has been successfully added to your 
